Latest Insider Transactions at Inogen Inc (INGN)
This section provides a real-time view of insider transactions for Inogen Inc (INGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inogen Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inogen Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2024
|
Gregoire Ramade Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,942
-41.0%
|
$116,478
$9.71 P/Share
|
|
Dec 01
2024
|
Gregoire Ramade Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,565
+50.0%
|
-
|
|
Dec 01
2024
|
Kevin Raymond Merrill Smith CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
13,779
-48.63%
|
$124,011
$9.71 P/Share
|
|
Dec 01
2024
|
Kevin Raymond Merrill Smith CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,333
+50.0%
|
-
|
|
Jun 05
2024
|
Heather D. Rider |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+27.52%
|
-
|
|
Jun 05
2024
|
Kevin M King |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Glenn S Boehnlein |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Elizabeth Mora |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+31.05%
|
-
|
|
Jun 05
2024
|
Mary Kay Ladone |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+32.1%
|
-
|
|
Jun 05
2024
|
Thomas A. West |
BUY
Grant, award, or other acquisition
|
Direct |
21,871
+34.97%
|
-
|
|
Jun 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-6.74%
|
$2,712
$8.3 P/Share
|
|
Jun 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+10.29%
|
-
|
|
May 10
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-69.19%
|
$80,000
$8.56 P/Share
|
|
May 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,695
-34.25%
|
$116,865
$7.05 P/Share
|
|
May 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,638
+40.1%
|
-
|
|
May 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,312
-43.91%
|
$79,184
$7.05 P/Share
|
|
May 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
19,276
+42.8%
|
-
|
|
Mar 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,576
-41.36%
|
$32,032
$7.03 P/Share
|
|
Mar 01
2024
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,150
+39.26%
|
-
|
|
Mar 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,623
-32.13%
|
$53,361
$7.03 P/Share
|
|
Mar 01
2024
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,914
+36.96%
|
-
|
|
Dec 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,331
-19.19%
|
$11,655
$5.72 P/Share
|
|
Dec 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,555
+27.27%
|
-
|
|
Dec 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-6.81%
|
$1,430
$5.72 P/Share
|
|
Dec 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
576
+12.06%
|
-
|
|
Sep 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
287
-7.34%
|
$1,722
$6.18 P/Share
|
|
Sep 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+12.86%
|
-
|
|
Sep 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-4.93%
|
$2,364
$6.18 P/Share
|
|
Sep 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
769
+8.78%
|
-
|
|
Sep 01
2023
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,942
-4.99%
|
$11,652
$6.18 P/Share
|
|
Sep 01
2023
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,686
+8.65%
|
-
|
|
Jun 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-5.16%
|
$3,930
$10.37 P/Share
|
|
Jun 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
768
+9.17%
|
-
|
|
Jun 01
2023
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-5.75%
|
$4,990
$10.37 P/Share
|
|
Jun 01
2023
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,126
+11.49%
|
-
|
|
Jun 01
2023
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,941
-5.22%
|
$19,410
$10.37 P/Share
|
|
Jun 01
2023
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,685
+9.02%
|
-
|
|
Jun 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-7.9%
|
$2,860
$10.37 P/Share
|
|
Jun 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
576
+13.73%
|
-
|
|
May 31
2023
|
Heather D. Rider |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+32.37%
|
-
|
|
May 31
2023
|
Thomas A. West |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+47.62%
|
-
|
|
May 31
2023
|
Glenn S Boehnlein |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+41.19%
|
-
|
|
May 31
2023
|
Kevin M King |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+41.19%
|
-
|
|
May 31
2023
|
Mary Kay Ladone |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+41.19%
|
-
|
|
May 31
2023
|
Elizabeth Mora |
BUY
Grant, award, or other acquisition
|
Direct |
17,094
+39.04%
|
-
|
|
Apr 01
2023
|
Thomas A. West |
BUY
Grant, award, or other acquisition
|
Direct |
1,712
+50.0%
|
-
|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,673
-7.1%
|
$25,095
$15.56 P/Share
|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,402
+16.2%
|
-
|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,135
+9.73%
|
-
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-27.84%
|
$30,180
$15.56 P/Share
|